开年以来近百家公司冲刺港股IPO 多家公司已在A股上市 “A+H”热潮涌动

Group 1 - The IPO rush in Hong Kong continues to gain momentum, with nearly 100 companies submitting applications to the Hong Kong Stock Exchange (HKEX) since the beginning of the year, including 13 on January 26 alone [2] - As of January 28, 96 companies have applied for the main board of HKEX, with 2 additional companies applying for the GEM (Growth Enterprise Market), including nearly 20 companies that are reapplying or have applied multiple times [2] - In January 2025, only 36 companies had submitted applications to HKEX, highlighting the significant increase in activity this year [2] Group 2 - The companies applying for IPOs are primarily from sectors such as software services, hardware, semiconductors, biomedicine, medical devices and services, and consumer goods [3] - Over 10 biotech companies are pursuing IPOs under Chapter 18A of the HKEX listing rules, focusing on unmet medical needs in oncology and immunology [3] - Notable biotech firms include Bangshun Pharmaceutical, Zeling Bio, and Qinhao Pharmaceutical, which are developing innovative therapies for various diseases [3] Group 3 - In the consumer sector, over 10 well-known brands, including Junlebao Dairy and Qian Dama, have submitted IPO applications, covering various niches such as food and beverage, restaurant chains, and community retail [4] - Analysts predict that the trend of consumer companies going public in Hong Kong will continue to thrive, with strong interest from professional capital in solid consumer enterprises [4] - The "A+H" trend is ongoing, with nearly 20 companies that have applied for IPOs in 2026 already listed on A-shares, indicating a strategic move to enhance global operations and financing channels [4] Group 4 - The phenomenon of A-share companies applying for HKEX listings has been observed since the fourth quarter of 2024, driven by policy opportunities, market cycles, and globalization strategies [5] - High-profile executives, such as Goldman Sachs' CEO, anticipate a strong recovery in the HKEX IPO market in 2026, expecting significant increases in both the number of IPOs and financing scale [5] - However, the surge in IPO applications has led to concerns about the quality of submissions, with some companies submitting incomplete applications and facing scrutiny over the quality of their documentation [5][6] Group 5 - HKEX's CEO emphasized that the recent decline in IPO quality is due to the sudden increase in applications, which has put pressure on resources and collaboration [6] - Maintaining high-quality standards for IPO applications is crucial for preserving market trust, and recent warnings have been issued regarding the need for thorough due diligence [6] - The balance between speed and quality in the IPO process is essential to ensure the integrity of the market [6]